DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
2 hedge funds and large institutions have $21K invested in DarioHealth Corp. Warrant in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
17% more capital invested
Capital invested by funds: $18K → $21K (+$3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPC
Waters Parkerson & Co
New Orleans,
Louisiana
|
+$5.46K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.67K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $14K | – | – | – |
|
|
WPC
2
Waters Parkerson & Co
New Orleans,
Louisiana
| $4K | +$5.46K | +20,000 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $3K | +$2.67K | +9,800 | +184% |
|
DRIOW Hedge Fund Activity: Q1 2018 in Review
2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q1 2018, worth a combined $21K — up 17% from $18K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new DRIOW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Waters Parkerson & Co, opening a new position worth an estimated $5.46K.
- 2 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q1 2018, up from 1 in Q4 2017.
- Funds reported $21K of DarioHealth Corp. Warrant stock for Q1 2018, up 17% quarter-over-quarter.
- 1 fund opened new DarioHealth Corp. Warrant positions in Q1 2018 and 0 closed out, a net change of +1 holder.
- The largest DarioHealth Corp. Warrant buyer in Q1 2018 was Waters Parkerson & Co, an estimated $5.46K added.
Based on aggregated 13F filings for Q1 2018.